Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Edit, Remák"'
2
Economic analysis of ceftaroline fosamil for treating community-acquired pneumonia in Spain
Autor: Matteo Bassetti, Claudie Charbonneau, Tobias Welte, W. Ansari, Santiago Grau, Edit Remák, Jennifer Hammond, Antoni Torres, C. Peral, Simone Rivolo
Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Background: Adults admitted to hospital with community-acquired pneumonia (CAP) impose significant burden upon limited hospital resources. To achieve early response and possibly early discharge, thus reducing hospital expenditure, the choice of initi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0598e6d59e0f37206d08743f301e8191
https://ddd.uab.cat/record/223854
Zobrazit plný text záznamu
3
A cost-consequence analysis of parecoxib and opioids vs opioids alone for postoperative pain: Chinese perspective
Autor: Magdolna, Barra, Edit, Remák, Dong Dong, Liu, Li, Xie, Lucy, Abraham, Alesia B, Sadosky
Publikováno v: ClinicoEconomics and Outcomes Research: CEOR
Purpose The use of parecoxib plus opioids for postoperative analgesia in noncardiac surgical patients seems to be cost-saving in Europe due to a reduction in opioid use and opioid-related adverse events. Given the lack of information on postoperative
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1bb6c4da602b376fff3a1dffa4c15742
https://pubmed.ncbi.nlm.nih.gov/30863130
Zobrazit plný text záznamu
4
A cost-utility analysis of adjunctive treatment with newer antiepileptic drugs in the UK
Autor: Caroline Selai, Michael R. Trimble, Edit Remák, John Hutton, Martin J. Price
Publikováno v: Journal of Medical Economics. 7:29-40
SummaryA recent review found that economic assessment of epilepsy treatment relies largely on hypothetical modelling of outcomes and combining these with resource and cost data from different sources. Prospective evaluations combining cost studies wi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::054c5f6fe31e4e8b884ca1cffc33842f
https://doi.org/10.3111/200407029040
Zobrazit plný text záznamu
5
Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma
Autor: Agnes, Benedict, Robert A, Figlin, Per, Sandström, Ulrika, Harmenberg, Anders, Ullén, Claudie, Charbonneau, Rickard, Sandin, Edit, Remák, Subramanian, Hariharan, Sylvie, Négrier
Publikováno v: BJU international. 108(5)
• To assess the economic value of targeted therapies as first-line metastatic renal cell carcinoma (mRCC) treatment in the US and Sweden by indirect comparison of survival data.• A Markov model simulated disease progression, adverse events and su
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d0b0c5851310f907b5b747e97d34f4ab
https://pubmed.ncbi.nlm.nih.gov/21265994
Zobrazit plný text záznamu
6
Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma
Autor: Claudie Charbonneau, Subramanian Hariharan, Sylvie Negrier, Per Sandström, A. Benedict, Ulrika Harmenberg, Robert A. Figlin, Edit Remák, Rickard Sandin, Anders Ullén
Publikováno v: BJU International.
Study Type – Therapy (economic) Level of Evidence 2b What’s known on the subject? and What does the study add? Cost-effectiveness of new targeted molecular therapies in patients with mRCC have been examined compared to interferon-α. This study c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e7ed5aeb6f8ee5d2c1d63835944b5887
https://doi.org/10.1111/j.1464-410x.2010.09957.x
Zobrazit plný text záznamu
7
Economic evaluation of sunitinib malate for the first-line treatment of metastatic renal cell carcinoma
Autor: Edit Remák, Robert J. Motzer, Sylvie Negrier, Claudie Charbonneau, Sindy T. Kim
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(24)
Purpose To assess the cost effectiveness and cost utility of sunitinib malate as a first-line treatment in metastatic renal cell carcinoma (mRCC) compared with interferon-alfa (IFN-α) and interleukin-2 (IL-2) from a US societal perspective. Methods
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fa69d198c93c38f6f2566ed4118a72f
https://pubmed.ncbi.nlm.nih.gov/18711190
Zobrazit plný text záznamu
8
Evaluation of health status in epilepsy using the EQ-5D questionnaire: a prospective, observational, 6-month study of adjunctive therapy with anti-epileptic drugs
Autor: Michael R. Trimble, Martin J. Price, Caroline Selai, Edit Remák
Publikováno v: Current medical research and opinion. 21(5)
The aims of this project were to evaluate the impact of adjunctive treatment with an anti-epileptic drug (AED) on the health status of people with epilepsy and to investigate how seizure frequency affects their health status.Adult epilepsy patients,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fd434caa35cd703a3952968c755e9b4
https://pubmed.ncbi.nlm.nih.gov/15969872
Zobrazit plný text záznamu
10
Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
Autor: Zoltán Kaló, Edit Remák, Márta Pékli, Orsolya Nagy, András Inotai, Gabriella Jóna
Publikováno v: BMC Health Services Research
BMC Health Services Research, Vol 12, Iss 1, p 332 (2012)
Background In middle income countries the number of trained health technology assessment specialists is limited and the public budget for health technology assessment is considerably lower compared to developed countries. These countries therefore mu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ae980775543779ee5315cc3395239d8
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje